United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - flurbiprofen - oral tablet - 50mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - flurbiprofen - oral tablet - 100mg

Canada - English - Health Canada

ratiopharm inc division of teva canada limited - flurbiprofen - tablet - 50mg - flurbiprofen 50mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

ratiopharm inc division of teva canada limited - flurbiprofen - tablet - 100mg - flurbiprofen 100mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

nu-pharm inc - flurbiprofen - tablet - 50mg - flurbiprofen 50mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

nu-pharm inc - flurbiprofen - tablet - 100mg - flurbiprofen 100mg - other nonsteroidal antiimflammatory agents

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - flurbiprofen (unii: 5gro578klp) (flurbiprofen - unii:5gro578klp) - flurbiprofen tablets are indicated: flurbiprofen tablets are contraindicated in the following patients: risk summary use of nsaids, including flurbiprofen tablets, can cause premature closure of the fetal ductus arteriosus and fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment. because of these risks, limit dose and duration of flurbiprofen tablets use between about 20 and 30 weeks of gestation, and avoid flurbiprofen tablets use at about 30 weeks of gestation and later in pregnancy [see clinical considerations, data ]. premature closure of fetal ductus arteriosus use of nsaids, including flurbiprofen tablets, at about 30 weeks gestation or later in pregnancy increases the risk of premature closure of the fetal ductus arteriosus. oligohydramnios/neonatal renal impairment use of nsaids at about 20 weeks gestation or later in pregnancy has been associated with cases of fetal renal dysfunction leading to oligohydramnios, and in some cases, neonatal renal impairment.

Canada - English - Health Canada

aa pharma inc - flurbiprofen - tablet - 100mg - flurbiprofen 100mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

aa pharma inc - flurbiprofen - tablet - 50mg - flurbiprofen 50mg - other nonsteroidal antiimflammatory agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - flurbiprofen - oral tablet - 50mg